Adamis Pharmaceuticals reported -309070 in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Adma Biologics ADMA:US $ 3.66M 0.15M
Glaxosmithkline GSK:US $ 4793M 1342M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Merk MRK:US $ 10895M 328M
Pfizer PFE:US $ 19071M 3420M
Redhill Biopharma RDHL:US $ 10.2M 1.44M